In This Article:
Compumedics (ASX:CMP) First Half 2025 Results
Key Financial Results
-
Revenue: AU$47.1m (up 78% from 1H 2024).
-
Net loss: AU$2.23m (down from AU$141.0k profit in 1H 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Compumedics shares are down 11% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 1 warning sign for Compumedics you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.